Catatan efek · kuartal yang diarsipkan
CRSP
CRISPR Therapeutics AG · Healthcare · Biotechnology
13Pemegang yang dilacak
0Δ pemegang
27.95MSaham yang dipegang
$1.36BNilai yang dilaporkan
+1Posisi baru
−1Keluar
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +4.1% · posisi baru bersih 0.0% — formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 115 | +5 | 51.84M | $2.83B | +10 | −4 |
| Q1 2026 | 112 | -2 | 52.07M | $2.48B | +5 | −8 |
| Q4 2025 | 114 | 0 | 52.74M | $2.77B | +1 | — |
| Q3 2025 | 15 | 0 | 31.49M | $2.04B | +1 | −2 |
| Q2 2025 | 13 | 0 | 27.95M | $1.36B | +1 | −1 |
| Q1 2025 | 10 | +2 | 16.56M | $563.38M | +2 | — |
| Q4 2024 | 8 | -2 | 14.13M | $556.07M | — | −2 |
| Q3 2024 | 9 | -1 | 10.14M | $476.58M | — | −1 |
| Q2 2024 | 10 | — | 10.63M | $574.07M | — | — |
Siapa yang memegangnya · Q2 2025
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 10.18M | +0.2% | $495.28M | 3.6% | ▲ Add | 5 | SEC ↗ |
| 2 | BlackRock ✦ (pasif) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasif) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasif) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasif) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasif) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasif) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasif) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasif) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasif) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasif) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (pasif) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (pasif) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (pasif) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (pasif) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (pasif) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (pasif) | 3.27M | +35.6% | $159.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | The Vanguard Group ✦ (pasif) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (pasif) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (pasif) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (pasif) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (pasif) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | The Vanguard Group ✦ (pasif) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Geode Capital Management ✦ (pasif) | 2.07M | +98.1% | $100.79M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Geode Capital Management ✦ (pasif) | 2.07M | +98.1% | $100.79M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 1.93M | — | $93.83M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 1.93M | — | $93.83M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Fidelity (FMR) ✦ | 1.93M | — | $93.83M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Two Sigma Investments ✦ | 1.55M | +30.0% | $75.20M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 30 | Norges Bank ✦ (pasif) | 406.49K | -10.9% | $19.77M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | Millennium Management ✦ | 70.09K | -88.0% | $3.41M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | T. Rowe Price ✦ | 66.37K | +142.5% | $3.23M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 21.61K | -14.6% | $1.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 21.61K | -14.6% | $1.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 21.61K | -14.6% | $1.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 21.61K | -14.6% | $1.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 37 | Citadel Advisors ✦ | 18.88K | -92.7% | $918,226 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | Gotham Asset Management ✦ | 5.10K | Baru | $248,113 | 0.0% | New | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Gotham Asset Management | $248,113 | 0.0% |
Telah keluar
| Marshall Wace | $13.38M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 488 pemegang, 76.60M saham, $3.47B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Aug 14
SC 13G/A — ORBIS INVESTMENT MANAGEMENT LTD
Jul 27
SC 13G/A — BlackRock, Inc.
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q2 2025 ·
Metodologi ·
Dapatkan ini melalui API